Balance Sheet Scilex Holding Company

Equities

SCLX

US80880W1062

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 16:00:00 2024-09-16 EDT			5-day change	1st Jan Change
1.090 ^USD	-5.22%		+6.86%	-46.57%

09-12	Scilex Gets Drug Distributor Accreditation from National Association of Boards of Pharmacy	MT
09-03	Scilex Unit Semnur Pharmaceuticals, Denali Capital Sign Merger Agreement	MT

960.ootjDQRcwUK-0mt7LsjmpAHSV1zzNTrJr9oRd465o2c.zaYTZXIDoiDUgzQJZq-n9WKLDQ6VREuswq5QOeLmlyua_xo0aAiGGJPjCA

Published financial data: SCILEX HOLDING COMPANY

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	21.03M	23.56M	31.32M	38.03M	46.74M
Total Revenues	21.03M	23.56M	31.32M	38.03M	46.74M
Cost of Goods Sold, Total	5.8M	2.15M	3.63M	10.8M	15.68M
Gross Profit	15.23M	21.41M	27.68M	27.24M	31.06M
Selling General & Admin Expenses, Total	64.7M	42.97M	50.58M	64.9M	120M
R&D Expenses	10.22M	9.96M	9.2M	9.05M	12.75M
Amortization of Goodwill and Intangible Assets - (IS)	3.71M	3.74M	3.74M	3.92M	4.11M
Other Operating Expenses, Total	78.62M	56.67M	63.52M	77.87M	136M
Operating Income	-63.39M	-35.26M	-35.84M	-50.63M	-105M
Interest Expense, Total	-16.89M	-13.12M	-11.76M	-9.6M	-1.07M
Interest And Investment Income	460K	-	-	-	-
Net Interest Expenses	-16.43M	-13.12M	-11.76M	-9.6M	-1.07M
Currency Exchange Gains (Loss)	-168K	2K	-54K	-66K	-118K
Other Non Operating Income (Expenses)	-23.3M	800K	-28.3M	8.31M	-512K
EBT, Excl. Unusual Items	-103M	-47.57M	-75.96M	-51.99M	-107M
In Process R&D Expenses	-75.3M	-	-	-	-
Other Unusual Items	-	-	-12.46M	28.63M	-7.19M
EBT, Incl. Unusual Items	-179M	-47.57M	-88.42M	-23.36M	-114M
Income Tax Expense	2K	-53K	5K	4K	13K
Earnings From Continuing Operations	-179M	-47.52M	-88.42M	-23.36M	-114M
Net Income to Company	-179M	-47.52M	-88.42M	-23.36M	-114M
Net Income - (IS)	-179M	-47.52M	-88.42M	-23.36M	-114M
Preferred Dividend and Other Adjustments	-	-	-	-	52.64M
Net Income to Common Incl Extra Items	-179M	-47.52M	-88.42M	-23.36M	-167M
Net Income to Common Excl. Extra Items	-179M	-47.52M	-88.42M	-23.36M	-167M
Per Share Items
Net EPS - Basic	-0.95	-0.24	-0.45	-0.17	-1.28
Basic EPS - Continuing Operations	-0.95	-0.24	-0.45	-0.17	-1.28
Basic Weighted Average Shares Outstanding	188M	197M	197M	134M	130M
Net EPS - Diluted	-0.95	-0.24	-0.45	-0.17	-1.28
Diluted EPS - Continuing Operations	-0.95	-0.24	-0.45	-0.17	-1.28
Diluted Weighted Average Shares Outstanding	188M	197M	197M	134M	130M
Normalized Basic EPS	-0.34	-0.15	-0.24	-0.24	-0.51
Normalized Diluted EPS	-0.34	-0.15	-0.24	-0.24	-0.51
Supplemental Items
EBITDA	-59.64M	-31.48M	-32.06M	-46.67M	-101M
EBITA	-59.68M	-31.52M	-32.1M	-46.71M	-101M
EBIT	-63.39M	-35.26M	-35.84M	-50.63M	-105M
EBITDAR	-58.87M	-30.58M	-31.44M	-46.2M	-100M
Effective Tax Rate - (Ratio)	-0	0.11	-0.01	-0.02	-0.01
Current Domestic Taxes	2K	-53K	5K	4K	13K
Total Current Taxes	2K	-53K	5K	4K	13K
Deferred Domestic Taxes	-	-	-	0	0
Total Deferred Taxes	-	-	-	0	0
Normalized Net Income	-64.56M	-29.73M	-47.47M	-32.5M	-66.96M
Interest on Long-Term Debt	-	-	-	-	4.4M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	85.52M	9.96M	9.2M	9.05M	12.75M
Net Rental Expense, Total	776K	904K	623K	469K	1.1M
Imputed Operating Lease Interest Expense	-	-	400K	462K	145K
Imputed Operating Lease Depreciation	-	-	223K	7.48K	955K
Stock-Based Comp., Other (Total)	4.33M	5.4M	5.82M	5.28M	14.6M
Total Stock-Based Compensation	4.33M	5.4M	5.82M	5.28M	14.6M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	-	4.84M	4.34M	2.18M	3.92M
Total Cash And Short Term Investments	-	4.84M	4.34M	2.18M	3.92M
Accounts Receivable, Total	-	13.13M	14.27M	21.24M	34.6M
Total Receivables	-	13.13M	14.27M	21.24M	34.6M
Inventory	-	1.14M	2.56M	1.38M	4.21M
Prepaid Expenses	-	3.31M	1.84M	4.81M	4.05M
Total Current Assets	-	22.42M	23M	29.61M	46.78M
Gross Property Plant And Equipment	-	2.61M	2.24M	2.07M	3.72M
Accumulated Depreciation	-	-88K	-127K	-167K	-58K
Net Property Plant And Equipment	-	2.52M	2.11M	1.9M	3.66M
Goodwill	-	13.48M	13.48M	13.48M	13.48M
Other Intangibles, Total	-	42.54M	38.8M	40.59M	36.48M
Other Long-Term Assets, Total	-	538K	538K	944K	897K
Total Assets	-	81.5M	77.93M	86.53M	101M
Liabilities
Accounts Payable, Total	-	8.12M	4.28M	8.45M	40.95M
Accrued Expenses, Total	-	14.38M	14.35M	35.38M	99.75M
Short-term Borrowings	-	13.01M	19.61M	-	-
Current Portion of Long-Term Debt	-	15.89M	37.95M	-	108M
Current Portion of Leases	-	424K	500K	745K	759K
Other Current Liabilities	-	26.66M	92.72M	264K	491K
Total Current Liabilities	-	78.48M	169M	44.84M	250M
Long-Term Debt	-	108M	95.54M	-	17.04M
Long-Term Leases	-	1.65M	1.15M	665K	2.24M
Other Non Current Liabilities	-	35.4M	35.7M	4.78M	4.59M
Total Liabilities	-	223M	302M	50.29M	274M
Preferred Stock Convertible	-	-	-	3K	-
Total Preferred Equity	-	-	-	3K	-
Common Stock, Total	-	20K	20K	14K	16K
Additional Paid In Capital	-	122M	129M	412M	408M
Retained Earnings	-	-264M	-353M	-376M	-490M
Treasury Stock	-	-	-	-	-90.52M
Total Common Equity	-	-142M	-224M	36.24M	-173M
Total Equity	-	-142M	-224M	36.24M	-173M
Total Liabilities And Equity	-	81.5M	77.93M	86.53M	101M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	188M	197M	197M	146M	106M
ECS Total Common Shares Outstanding	188M	197M	197M	141M	100M
Book Value / Share	-	-0.72	-1.13	0.26	-1.73
Tangible Book Value	-	-198M	-276M	-17.84M	-223M
Tangible Book Value Per Share	-	-1	-1.4	-0.13	-2.23
Total Debt	-	139M	155M	1.41M	128M
Net Debt	-	134M	150M	-774K	125M
Debt Equivalent Oper. Leases	6.21M	7.23M	4.98M	3.75M	8.8M
Account Code - Inventory Valuation	-	-	5	5	5
Machinery, Total	-	195K	195K	195K	41K
Full Time Employees	-	-	76	90	105

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	-179M	-47.52M	-88.42M	-23.36M	-114M
Depreciation & Amortization - CF	37K	39K	41K	39K	40K
Amortization of Goodwill and Intangible Assets - (CF)	3.71M	3.74M	3.74M	3.92M	4.11M
Depreciation & Amortization, Total	3.75M	3.78M	3.78M	3.96M	4.15M
Amortization of Deferred Charges, Total - (CF)	15.03M	10.66M	7.91M	3.14M	65K
Stock-Based Compensation (CF)	4.33M	5.4M	5.82M	5.28M	14.6M
Other Operating Activities, Total	99.13M	-10.84M	28.65M	-55.94M	9.02M
Change In Accounts Receivable	-12.36M	-598K	-1.14M	-6.97M	-13.36M
Change In Inventories	-1.12M	2.38M	-1.42M	1.18M	-2.84M
Change In Accounts Payable	4.27M	-4.06M	-3.84M	2.81M	19.88M
Change in Other Net Operating Assets	5.13M	9.34M	20M	48.65M	62.12M
Cash from Operations	-60.42M	-31.46M	-28.66M	-21.26M	-20.71M
Capital Expenditure	-584K	-25K	-	-7K	-30K
Cash Acquisitions	-17.04M	-	-	-	-
Sale (Purchase) of Intangible assets	-	-	-	-2.06M	-300K
Cash from Investing	-17.62M	-25K	-	-2.07M	-330K
Short Term Debt Issued, Total	-	18.4M	47.85M	51.9M	-
Long-Term Debt Issued, Total	21.63M	21.31M	62.53M	72.36M	110M
Total Debt Issued	21.63M	39.71M	110M	124M	110M
Long-Term Debt Repaid, Total	-5.85M	-58.93M	-82.22M	-104M	-84.63M
Total Debt Repaid	-5.85M	-58.93M	-82.22M	-104M	-84.63M
Issuance of Common Stock	-	50K	-	96K	36.59M
Repurchase of Common Stock	-	-	-	-	-10M
Other Financing Activities, Total	-	-	-	426K	-28.74M
Cash from Financing	15.78M	-19.17M	28.16M	21.17M	23.58M
Net Change in Cash	-62.27M	-50.66M	-501K	-2.15M	2.54M
Supplemental Items
Cash Interest Paid	-	-	-	-	1.43M
Levered Free Cash Flow	-	-	48.88M	-103M	33.57M
Unlevered Free Cash Flow	-	-	48.32M	-100M	34.18M
Change In Net Working Capital	-	-	-61.12M	76.02M	-81.66M
Net Debt Issued / Repaid	15.78M	-19.22M	28.16M	20.65M	25.73M

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	-	-	-28.1	-38.49	-70.16
Return on Total Capital	-	-	62.06	201.05	1.93K
Return On Equity %	-	-	48.38	24.9	167.27
Return on Common Equity	-	-	48.38	24.9	244.29
Margin Analysis
Gross Profit Margin %	72.41	90.88	88.4	71.61	66.45
SG&A Margin	307.59	182.39	161.52	170.62	255.95
EBITDA Margin %	-283.57	-133.62	-102.37	-122.71	-216.68
EBITA Margin %	-283.75	-133.79	-102.5	-122.82	-216.77
EBIT Margin %	-301.4	-149.65	-114.44	-133.13	-225.55
Income From Continuing Operations Margin %	-849.11	-201.69	-282.35	-61.43	-244.59
Net Income Margin %	-849.11	-201.69	-282.35	-61.43	-244.59
Net Avail. For Common Margin %	-849.11	-201.69	-282.35	-61.43	-357.22
Normalized Net Income Margin	-306.93	-126.2	-151.59	-85.44	-143.24
Levered Free Cash Flow Margin	-	-	156.08	-271.75	71.83
Unlevered Free Cash Flow Margin	-	-	154.31	-264.23	73.12
Asset Turnover
Asset Turnover	-	-	0.39	0.46	0.5
Fixed Assets Turnover	-	-	13.53	18.96	16.79
Receivables Turnover (Average Receivables)	-	-	2.29	2.14	1.67
Inventory Turnover (Average Inventory)	-	-	1.96	5.48	5.61
Short Term Liquidity
Current Ratio	-	0.29	0.14	0.66	0.19
Quick Ratio	-	0.23	0.11	0.52	0.15
Operating Cash Flow to Current Liabilities	-	-0.4	-0.17	-0.47	-0.08
Days Sales Outstanding (Average Receivables)	-	-	159.64	170.36	217.99
Days Outstanding Inventory (Average Inventory)	-	-	186.17	66.6	65.08
Average Days Payable Outstanding	-	-	448.17	241.75	486.92
Cash Conversion Cycle (Average Days)	-	-	-102.37	-4.79	-203.85
Long Term Solvency
Total Debt/Equity	-	-97.84	-69.12	3.89	-74.28
Total Debt / Total Capital	-	-4.54K	-223.85	3.75	-288.84
LT Debt/Equity	-	-77.15	-43.19	1.84	-11.15
Long-Term Debt / Total Capital	-	-3.58K	-139.86	1.77	-43.34
Total Liabilities / Total Assets	-	273.84	387.27	58.12	270.7
EBIT / Interest Expense	-3.75	-2.69	-3.05	-5.27	-98.72
EBITDA / Interest Expense	-3.53	-2.33	-2.67	-4.81	-93.81
(EBITDA - Capex) / Interest Expense	-3.57	-2.33	-2.67	-4.81	-93.83
Total Debt / EBITDA	-	-4.53	-4.92	-0.03	-1.28
Net Debt / EBITDA	-	-4.38	-4.78	0.02	-1.24
Total Debt / (EBITDA - Capex)	-	-4.53	-4.92	-0.03	-1.28
Net Debt / (EBITDA - Capex)	-	-4.37	-4.78	0.02	-1.24
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	12.01	32.92	21.45	22.9
Gross Profit, 1 Yr. Growth %	-	40.58	29.29	-1.61	14.04
EBITDA, 1 Yr. Growth %	-	-47.22	1.84	45.58	117.01
EBITA, 1 Yr. Growth %	-	-47.19	1.84	45.52	116.91
EBIT, 1 Yr. Growth %	-	-44.38	1.64	41.29	108.22
Earnings From Cont. Operations, 1 Yr. Growth %	-	-73.39	86.08	-73.58	389.35
Net Income, 1 Yr. Growth %	-	-73.39	86.08	-73.58	389.35
Normalized Net Income, 1 Yr. Growth %	-	-53.94	59.67	-31.55	106.04
Diluted EPS Before Extra, 1 Yr. Growth %	-	-74.71	86.86	-74.02	636.22
Accounts Receivable, 1 Yr. Growth %	-	-	8.7	48.84	62.92
Inventory, 1 Yr. Growth %	-	-	123.76	-46.21	205.81
Net Property, Plant and Equip., 1 Yr. Growth %	-	-	-16.38	-9.72	92.59
Total Assets, 1 Yr. Growth %	-	-	-4.38	11.03	17.08
Tangible Book Value, 1 Yr. Growth %	-	-	39.68	-93.54	1.15K
Common Equity, 1 Yr. Growth %	-	-	58.01	-116.19	-577.25
Cash From Operations, 1 Yr. Growth %	-	-47.93	-8.89	-25.84	-2.59
Capital Expenditures, 1 Yr. Growth %	-	-95.72	-	-	328.57
Levered Free Cash Flow, 1 Yr. Growth %	-	-	-	-311.45	-132.48
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-	-	-307.96	-134.01
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	22.02	27.06	22.17
Gross Profit, 2 Yr. CAGR %	-	-	34.82	12.79	5.93
EBITDA, 2 Yr. CAGR %	-	-	-26.69	21.76	77.75
EBITA, 2 Yr. CAGR %	-	-	-26.66	21.74	77.67
EBIT, 2 Yr. CAGR %	-	-	-24.81	19.84	71.52
Earnings From Cont. Operations, 2 Yr. CAGR %	-	-	-29.64	-29.88	13.71
Net Income, 2 Yr. CAGR %	-	-	-29.64	-29.88	13.71
Normalized Net Income, 2 Yr. CAGR %	-	-	-14.25	4.54	18.76
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	-31.26	-30.46	38.3
Accounts Receivable, 2 Yr. CAGR %	-	-	-	27.2	55.72
Inventory, 2 Yr. CAGR %	-	-	-	9.7	28.25
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-	-	-13.12	31.86
Total Assets, 2 Yr. CAGR %	-	-	-	3.04	14.02
Tangible Book Value, 2 Yr. CAGR %	-	-	-	-69.96	-10.16
Common Equity, 2 Yr. CAGR %	-	-	-	-49.43	-12.11
Cash From Operations, 2 Yr. CAGR %	-	-	-31.12	-17.8	-15.01
Capital Expenditures, 2 Yr. CAGR %	-	-	-	-47.08	-
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-	-	-17.12
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-	-	-15.9
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	-	21.83	25.66
Gross Profit, 3 Yr. CAGR %	-	-	-	21.38	13.2
EBITDA, 3 Yr. CAGR %	-	-	-	-7.85	47.63
EBITA, 3 Yr. CAGR %	-	-	-	-7.84	47.59
EBIT, 3 Yr. CAGR %	-	-	-	-7.22	44.07
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	-	-49.24	34
Net Income, 3 Yr. CAGR %	-	-	-	-49.24	34
Normalized Net Income, 3 Yr. CAGR %	-	-	-	-20.45	31.07
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-	-43.25	52.69
Accounts Receivable, 3 Yr. CAGR %	-	-	-	-	38.13
Inventory, 3 Yr. CAGR %	-	-	-	-	54.39
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	-	-	13.28
Total Assets, 3 Yr. CAGR %	-	-	-	-	7.52
Tangible Book Value, 3 Yr. CAGR %	-	-	-	-	4.08
Common Equity, 3 Yr. CAGR %	-	-	-	-	6.87
Cash From Operations, 3 Yr. CAGR %	-	-	-	-29.4	-13.01
Capital Expenditures, 3 Yr. CAGR %	-	-	-	-77.11	6.27